Scientists Identify Post-Infection Treatment For Covid: Study

Treatment with a deuterated variant starting at 24 hours post-infection resulted in significantly increased survival of mice compared to untreated mice, the researchers said.

Scientists have identified a post-infection treatment for SARS-CoV-2, the virus that causes COVID-19, and successfully demonstrated its efficacy in stopping viral reproduction in mice. The study, published in the journal Proceedings of the National Academy of Sciences, shows that animal models infected with SARS-CoV-2 and treated with an inhibitor of protease enzymes had significantly increased survival and decreased lung viral quantity. These protease inhibitors are a class of antiviral drugs that prevent viral reproduction by selectively binding to viral enzymes and blocking the activation of proteins that are necessary for the production of infectious viral particles. "We developed the protease inhibitor GC376 for treating a fatal coronavirus infection in cats, which is now under commercial development as an investigational new animal drug," said Yunjeong Kim, associate professor at Kansas State University in the US.